tag:health.sourceofnews.net,2010://2 2007-09-15T10:27:52Z It is ARCHIVE SITE of the press release related to beauty and health. Movable Type Pro 5.01 tag:health.sourceofnews.net,2007://2.19030 2007-09-14T10:26:40Z 2007-09-15T10:27:52Z

The Premier Inc. healthcare alliance and...

About Wye River Group on Healthcare and the Foundation for American Health Care Leadership Wye River Group on Healthcare (WRGH) and its affiliate Foundation for American Health Care Leadership (FAHCL) are not-for-profit 501C3 forums for collaboration and open exchange of ideas to promote constructive healthcare system change. Both organizations identify and advance ideas with broad application to healthcare policy and the marketplace, through multiple educational outlets. Accountability, standard setting and a strong safety net is needed in a true system of healthcare. We believe that the best way to achieve these objectives is through public-private collaboration. We look for what is working and build on the many community-based partnerships throughout our country. For more information, visit www.wrgh.org. About Premier, 2006 Malcolm Baldrige National Quality Award recipient Serving 1,700 hospitals and more than 47,000 other healthcare sites, Premier is the largest healthcare alliance in the United States dedicated to improving patient outcomes while safely reducing the cost of care. Owned by not-for-profit hospitals, Premier operates the nation's largest healthcare purchasing network, the most comprehensive repository of hospital clinical and financial information and one of the largest policy-holder owned, hospital professional liability risk-retention groups in healthcare. Headquartered in San Diego, Premier has offices in Charlotte, N.C., Philadelphia, and Washington. For more information, visit www.premierinc.com. ]]> tag:health.sourceofnews.net,2007://2.19029 2007-09-14T10:24:40Z 2007-09-15T10:26:19Z

Harvard Bioscience, Inc. (Nasdaq: HBIO),...

www.harvardbioscience.com and at http://www.wsw.com/webcast/agc6/hbio/. Mr. Green's presentation will be available at the conference or can be downloaded from our website by clicking on the investor presentation icon. The presentation will cover the historical and expected future performance of the business. There will be a question and answer session following the presentation. Some of the information to be presented by Mr. Green or provided in response to questions may contain information that has not previously been disclosed. Additionally, any material financial or other statistical information presented in our presentation or in the question and answer session, which has not been previously disclosed will be archived and available in the Investor Relations section of our website. About Harvard Bioscience Harvard Bioscience is a global developer, manufacturer and marketer of a broad range of specialized products, primarily scientific instruments and apparatus, used to advance life science research at pharmaceutical and biotechnology companies, universities and government laboratories worldwide. HBIO sells its products to thousands of researchers in over 100 countries, through its 1,100 page catalog (and various other specialty catalogs), its website and through its distributors, including GE Healthcare, Thermo Fisher Scientific and VWR. HBIO has sales and manufacturing operations in the United States, the United Kingdom, Germany and Austria with additional facilities in France and Canada. For more information, please visit www.harvardbioscience.com. For investor inquiries, please call (508) 893-8066. Press releases may be found on our web site, http://www.harvardbioscience.com. ]]> tag:health.sourceofnews.net,2007://2.19028 2007-09-14T10:22:49Z 2007-09-15T10:24:30Z

Cincinnati Sub-Zero (CSZ), a developer o...

Cincinnati Sub-Zero (CSZ), a developer of advanced patient temperature management systems, including highly effective and efficient cooling products, recently reviewed the results of successive years of cooling therapy studies around the world. Studies of the impact of therapeutic cooling show reduced long-term brain damage and improved neurological function in sudden cardiac arrest patients. In the last few days, a professional football player and his doctors may have demonstrated similar neurological treatment benefits in association with spinal cord injury. Cincinnati Sub-Zero (CSZ), a developer of advanced patient temperature management systems, including highly effective and efficient cooling products, recently reviewed the results of successive years of cooling therapy studies around the world. "Improved outcomes in out-of-hospital cardiac arrest patients is clear in study after study of therapeutic hypothermia solutions -- and these are human trials that have taken place in the US, Canada, Norway, Sweden, and other countries," said Mark Beran, Vice President and General Manager of CSZ Medical. "ILCOR (The International Liaison Committee on Resuscitation) produced the first international guidelines to include therapeutic cooling in 2000. The New England Journal of Medicine first noted hypothermia treatment benefits to cardiac patients in 2002. The American Heart Association published a therapy-supportive advisory statement in 2003, following an international standard-setting review. And, the international community issued additional recommendations in 2005. More and more emergency services providers are adopting the treatment, and it is increasingly clear that the solution timing -- the sooner, the better -- is vital," said Beran. Where therapeutic cooling has been shown to halt brain cell death, it now may very well be illustrating it also can hinder spinal nerve death. In the case of the football player's neurological damage, doctors and experts speculate the hypothermia may have contributed to slowing his body's ability to produce swelling and irritation, reducing the possibility of spinal nerve death. While controversy still exists regarding the exact means of neurological improvement, studies do show that patients receiving controlled cooling therapy are more likely to survive their hospital stay, and be discharged with more neurological function. The 1st Annual International Therapeutic Temperature Management (TTM Congress) will be held in Cancun, Mexico from December 4-7, 2007. The TTM Congress will convene experts from around the world to review practices and research in therapeutic hypothermia and patient temperature modulation. CSZ Medical is an unrestricted educational grant sponsor for the event. More information is available at http://www.ttmcongress.com. About Cincinnati Sub-Zero and Cincinnati Sub-Zero, Medical Division The parent of three separate divisions, Cincinnati Sub-Zero (CSZ) is a leading manufacturer and provider of temperature management products for medical and industrial needs. CSZ is the customer-focused manufacturer of multiple therapeutic temperature control products for the healthcare market, a complete line of industrial environmental simulation testing chambers and a first-class, on-site testing laboratory. Cincinnati Sub-Zero, Medical Division has delivered patient temperature management systems to healthcare professionals since 1963, always designed with the patient in mind. The complete line of products includes therapeutic heat therapy, cold therapy units along with a complete line of warming blankets and cooling blankets for body temperature regulation and hyper-hypothermia treatment. The Whole Body Cooling System is designed for induced clinical hypothermia and it provides an effective alternative to traditional patient cooling techniques. This revolutionary system combines a Kool Kit® (the CSZ Head Wrap, Patient Vest and custom lower body pad) and the Blanketrol® III Hypo-Hyperthermia system. In addition, CSZ recently introduced the Gelli Roll® to its line of Hyper-hypothermia pads. This unique pad combines temperature management with tissue pressure reduction and will provide unique opportunities for warming and cooling your most challenging patients. CSZ also offers a wide variety of Hypo-Hyperthermia blankets that can be utilized with the Blanketrol® line. These single-patient use or reusable blankets are designed for quick, even-temperature distribution and efficient circulation, which make them the ideal choice for warming and cooling. Please visit http://www.cszmedical.com to learn more about CSZ, Medical Division. Forward-Looking Statements Except for statements of historical fact, the matters discussed in this press release are forward-looking and reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond our control and may cause actual results to differ materially from stated expectations. We undertake no obligation to release publicly the results of any revisions to these forward-looking statements to reflect events or circumstances arising after the date hereof. ]]> tag:health.sourceofnews.net,2007://2.19027 2007-09-14T10:21:13Z 2007-09-15T10:22:43Z

Pfizer Inc said today that the company p...

Investor Meeting Webcast: Pfizer Inc invites investors and the general public to listen to a webcast of a meeting with investment analysts to be held on Tuesday, September 18, at 6:00 p.m. Central Daylight Savings Time. The analyst meeting will include presentations by Pfizer’s anti-infective leadership team. To listen to the webcast, visit our web site at www.pfizer.com and click on the “Pfizer Anti-infective at ICAAC” link in the Investors Presentations tab on our homepage. Information on accessing and pre-registering for the webcast will be available at www.pfizer.com beginning today. Visitors will be able to view and listen to an archived copy of the webcast at www.pfizer.com. ]]> tag:health.sourceofnews.net,2007://2.19026 2007-09-14T10:19:56Z 2007-09-15T10:21:09Z

Addiction Community Resource Site Now Pr...

Addiction Community Resource Site Now Provides Telephone Supplement for Those in Need, 24 Hours a Day, Seven Days a Week Addicted.com, a website for addicts and their families to find support and recovery resources online, has announced a 24-hour, seven-day-a-week, toll-free number as an additional resource to addicts and their families. The toll-free “LifeLine” number, 877-ADDICTED, enables people struggling with addiction or their families to reach a live, specially trained Addicted.com supervisor who can give advice and refer callers to centers near them that specialize in treating their specific addictions. The number has been added to the Addicted.com site as a way to expand upon the site’s accessibility to all of those in need. “It is extremely gratifying to be able to add a toll-free, all-access number to our Addicted.com site,” said Addicted.com Founder and CEO John S. Shegerian. “We’ve worked hard to make Addicted.com a comprehensive place that people can visit from their computers, but we are also aware that there are those who may not have access to a computer who also need help. With that in mind we established our first-of-its-kind, free, 24-hour LifeLine. With more than 40 million addicts in the United States alone, there is an enormous population of individuals out there struggling with addiction who just need something like Addicted.com or our new LifeLine to kick-start their road to recovery.” The Addicted.com site itself features a full slate of professional addiction experts that specialize in the diagnosis and treatment of common addictions including eating disorders, sexual addiction, gambling and drug and alcohol addiction. The site also offers people seeking help a proprietary Zip Code Locator which visitors can use to find nearby recovery centers, doctors, counselors and other assistance for their addictions. Other features include AddictedTube, which allows visitors to view and share addiction-related videos. AddictedSpace is another valuable feature where members can share progress on recovery, ask for help, and share stories of addiction and rehabilitation. The site is also the first of its kind to feature virtual tours of treatment facilities so that people struggling with addictions and their families and loved ones can get a sense of the treatment options available in advance. Along with AddictedSpace and AddictedTube, visitors can take self-tests to help determine whether they have an addiction and may need to seek help. Articles, advice, experts and other resources give users the option of complete anonymity if they are seeking resources but aren’t ready to share their story with the world. Addicted.com also features an online “Aftercare” program, designed to continue giving support to addicts after their treatment has ended. Addicted.com provides addiction recovery resources and tools for addicts, family members and friends throughout the Internet community. The main goal of the site is to maintain a well-known online space for people to visit when they need advice, answers, assistance or just someone to talk with. For more information on addicted.com, its mission and services, please visit www.addicted.com or contact info@addicted.com, 1-866-ADDICTED. To reach the new 24-hour LifeLine, please call 1-877-ADDICTED. ]]> tag:health.sourceofnews.net,2007://2.19025 2007-09-14T10:18:12Z 2007-09-15T10:19:49Z

National Survey Reveals Majority of Smal...

National Survey Reveals Majority of Small Businesses Are Unprepared A national survey of small businesses conducted by the American Red Cross and FedEx Corp. (NYSE: FDX) found that while 94 percent of small business owners believe there is a potential for a disaster to seriously disrupt their business within the next two years, only 43 percent feel prepared for a one week disruption of their business, and 22 percent feel prepared for a one month disruption. Importantly, many businesses do want to become better prepared, with almost a quarter of respondents indicating they are planning on taking steps to prepare their businesses for disaster. Based on these findings, the American Red Cross and FedEx Corp. will create tools to help small businesses get prepared. FedEx and the Red Cross have been working together to examine small business disaster preparedness because of the important role small businesses play in the national and global economy, as well as the safety and strength of the communities in which they are located. “Having responded to more than 75,000 disasters nationwide last year, we’ve seen first hand how businesses with trained employees, protected resources and plans for operational continuity can decrease the physical and financial impact of a disaster, and lessen the burden on first responders,” said Darlene Sparks Washington, Director of Preparedness for the American Red Cross. “All businesses should have a disaster plan, but for small businesses, being prepared can make a difference in being able to stay in business after a disaster.” The survey data is especially relevant considering that one in four businesses do not reopen after a major disaster such as a flood, tornado or earthquake, according to the Institute for Business and Home Safety, and considering that small businesses account for more than 99 percent of businesses in the United States alone. “Disaster preparedness and contingency planning are core competencies at FedEx,” said David Bronczek, president and CEO of FedEx Express. “In addition to helping small businesses grow by providing unrivaled access to the global marketplace, we are delighted to leverage our planning expertise in collaboration with the American Red Cross to benefit small businesses in their disaster preparedness efforts.” While small businesses have taken some steps to prepare their business and their employees in advance of a disaster, they lag behind on several important indicators. A majority of businesses surveyed have developed employee phone lists for notifications and communication during a disaster (86 percent); ensured the safety of important business files or records (75 percent); and purchased insurance for business disruption or damage (80 percent). But businesses are much less likely to have completed other important steps. Only 41 percent have taken preparedness steps based on the type of disasters common to the business location and only 55 percent have communicated with employees about their roles before and during a disaster. Stacey Wieder is a practice manager at Lake Seminole Animal Hospital in Florida. She manages the hospital’s disaster planning for its 13 employees. The Lake Seminole Animal Hospital had to evacuate and utilized shutdown procedures during Hurricanes Charley and Jeanne in 2004. “By planning ahead for emergencies, the hospital is demonstrating to employees that their personal safety is important. Our employees have become better preparedness advocates and clients even tell us that our proactive planning has encouraged them to take preparedness steps,” said Wieder. The Red Cross and FedEx are developing preparedness solutions to help small business owners develop an emergency plan and help their employees get prepared. A downloadable disaster preparedness checklist for small businesses will be made available at www.fedex.com/smallbiz, as well as discount coupons which FedEx small business customers can use to receive 10 percent off their final purchase of preparedness supplies at the Red Cross online store, www.redcross.org/store, from September 10, 2007- October 31, 2007. Additional information on how small businesses, individuals and families can prepare for disasters is available at www.redcross.org or by contacting your local Red Cross chapter. Survey Methodology Macro International, Inc. conducted telephone surveys with 241 small businesses in June, 2007 to learn about how prepared they are for disasters, what specific steps they have taken, plan to take or have decided not to take to become prepared, and to gather information about tools and various resources that would assist them in preparing their business for a disaster. A random national sample of 101 small businesses has a margin of error of +/- 9.8% at a confidence level of 95%. Minority owned businesses and businesses located in disaster prone areas were over sampled to understand specific needs and characteristics among these two groups to inform development of emergency preparedness materials and tools that encourage businesses to take action steps. For purposes of this study, the definition of a small business is fewer than 100 employees but also a minimum of seven-10 employees. About The American Red Cross The American Red Cross helps people prevent, prepare for and respond to emergencies. Last year, almost a million volunteers and 35,000 employees helped victims of almost 75,000 disasters; taught lifesaving skills to millions; and helped U.S. service members separated from their families stay connected. Almost 4 million people gave blood through the Red Cross, the largest supplier of blood and blood products in the United States. The American Red Cross is part of the International Red Cross and Red Crescent Movement. An average of 91 cents of every dollar the Red Cross spends is invested in humanitarian services and programs. The Red Cross is not a government agency; it relies on donations of time, money, and blood to do its work. FedEx and the American Red Cross FedEx has worked with the American Red Cross for 10 years. A founding member of the Annual Disaster Giving Program, FedEx contributes more than $1 million in cash and in-kind services to the Red Cross every year. Recently, FedEx was presented with the Circle of Humanitarians award in gratitude for its generous contributions and longstanding commitment to the humanitarian mission of the organization. FedEx supports the American Red Cross Annual Disaster Giving Program as well as the International Federation of Red Cross/Red Crescent Societies. FedEx also has supported Red Cross efforts as needs have arisen for specific disaster initiatives such as Hurricane Katrina and many others. In addition, FedEx also lends logistics expertise to the Red Cross and thousands of FedEx employees directly volunteer. About FedEx FedEx Corp. (NYSE: FDX) provides customers and businesses worldwide with a broad portfolio of transportation, e-commerce and business services. With annual revenues of $35 billion, the company offers integrated business applications through operating companies competing collectively and managed collaboratively, under the respected FedEx brand. Consistently ranked among the world's most admired and trusted employers, FedEx inspires its more than 280,000 employees and contractors to remain "absolutely, positively" focused on safety, the highest ethical and professional standards and the needs of their customers and communities. For more information, visit http://news.fedex.com. ]]> tag:health.sourceofnews.net,2007://2.19024 2007-09-14T10:16:51Z 2007-09-15T10:17:57Z

Calypte Biomedical Corporation (OTCBB: C...

www.calypte.com in the Investor Relations section under Webcasts and Presentations. About Calypte Biomedical: Calypte Biomedical Corporation (www.calypte.com) is a U.S.-based healthcare company focused on the development and commercialization of rapid testing products for sexually transmitted diseases such as the Aware® HIV-1/2 OMT test that are suitable for use at the point of care and at home. Calypte believes there is a significant need for rapid detection of such diseases globally to control their proliferation, particularly in developing countries, which lack the medical infrastructure to support laboratory-based testing. Calypte believes that testing for HIV and other sexually transmitted infectious diseases may make important contributions to public health, and could increase the likelihood of treating those with undetected HIV and other sexually transmitted diseases. Statements in this press release that are not historical facts are forward-looking statements within the meaning of the Securities Act of 1933, as amended. Those statements include statements regarding the intent, belief or current expectations of the Company and its management. Such statements reflect management's current views, are based on certain assumptions and involve risks and uncertainties. Actual results, events, or performance may differ materially from the above forward-looking statements due to a number of important factors, and will be dependent upon a variety of factors, including, but not limited to, the Company's ability to obtain additional financing, if and as needed, and access funds from its existing financing arrangements that will allow it to continue its current and future operations and whether demand for its test products in domestic and international markets will generate sufficient revenues to achieve positive cash flow and profitability. The Company undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in the Company's expectations with regard to these forward-looking statements or the occurrence of unanticipated events. Factors that may impact the Company's success are more fully disclosed in the Company's most recent public filings with the U.S. Securities and Exchange Commission ("SEC"), including its annual report on Form 10-KSB for the year ended December 31, 2006 and its subsequent filings with the SEC. ]]> tag:health.sourceofnews.net,2007://2.19023 2007-09-14T10:15:17Z 2007-09-15T10:16:24Z

Empyrean Benefit Solutions adds a 250,00...

Empyrean Benefit Solutions adds a 250,000 life franchise organization to distribute and administer health benefits on their product, service and technology platform in all 50 states. Empyrean Benefit Solutions, Inc., an emerging leader in the benefit solution market, has added a 250,000 life franchise organization to its client base. The franchise organization will offer the Empyrean privately branded platform of product, technology and service to its franchisee employees and owners. “We continue to win these very large opportunities because we have a solution these groups have not been able to find anywhere else in the marketplace,” says Mike Mackey, President and COO of Empyrean Benefit Solutions. Empyrean’s clients range from large franchise organizations, to large associations to Fortune 1000 Corporations. Empyrean provides proprietary technology, service and a broad range of health and benefit products delivered through one portal and service center. Most of Empyrean’s clients are contracted for an integrated delivery of product, service and technology although an organization can choose only the technology and service in an outsourced form. Empyrean Benefit Solution distributes leading healthcare and benefit programs across many carriers in 50 states with prices affordable to everyone from full-time employees to part-time employees. “We’re very proud of the quick growth in our business. There seems to be an increasing focus on offering a range of healthcare options to all employees and staff, including part-time, online as a competitive business advantage,” says David Carlson, Chairman and CEO of Empyrean Benefit Solutions. About Empyrean Benefit Solutions, Inc. Empyrean Benefit Solutions develops cost effective, high quality healthcare group and voluntary benefit programs with its partners that are available in all 50 states. The plans are administered on an outsourced basis utilizing a state of the art, scalable technology and services platform. Empyrean’s flexible technology platform lets members select product, enroll in group or individual plans via the web or phone while providing ongoing support using the web, IVR and inbound call centers. With the company’s healthcare data analytics capability imbedded in the platform, clients also receive meaningful analysis of their healthcare expenditures. For more information, visit www.empyreanbenefits.com or call 800-934-1451. ]]> tag:health.sourceofnews.net,2007://2.19022 2007-09-14T10:14:19Z 2007-09-15T10:15:12Z

Pilgrim Software, Inc., a world-leading ...

About Pilgrim Software, Inc. Pilgrim Software, Inc. is a world-leading provider of Enterprise Compliance and Quality Management solutions for global organizations. Named 2007 North American Enterprise Compliance & Quality Management Company of the Year by Frost & Sullivan, Pilgrim helps organizations manage industry and regulatory compliance, reduce manufacturing costs and improve customer satisfaction. For more information, visit Pilgrim Software’s website at www.pilgrimsoftware.com. ]]> tag:health.sourceofnews.net,2007://2.19021 2007-09-14T10:12:50Z 2007-09-15T10:14:15Z

– Largest consumer-driven health plan in...

– Largest consumer-driven health plan in FEHB announces its latest innovation to simplify and improve health interactions for federal enrollees – – Aetna’s Personal Health Record, powered by the ActiveHealth® patented CareEngine® system, provides personalized alerts to members and physicians about opportunities to improve care – Aetna (NYSE:AET) announced today that as of January 2008, every federal enrollee that selects an Aetna medical plan will gain access to a password-protected, online Personal Health Record (PHR) that provides a centralized resource for health information and delivers personalized alerts to improve health care. As of September 1st, 26,000 Aetna federal enrollees already have access to an Aetna PHR. “We are committed to helping simplify and improve our members’ interactions with the health care system,” said Tom Bernatavitz, Aetna vice president of Federal Plans. “The Aetna PHR is the latest example of how we’re identifying opportunities for our federal members to increase access to information to help improve their health, as well as improving convenience,” he said. “It is a great help for busy families trying to keep track of immunizations on their children, as well as for federal enrollees that travel. They can access their personal health information 24 hours a day, seven days a week from anywhere in the world,” Bernatavitz explained. Aetna PHR works in the background to improve health Last year Aetna was the first to show its federal members physician-specific price information, clinical quality and efficiency data in selected markets. “Now we are arming our federal members with a powerful Personal Health Record that contains not only important data about their health, but actually works to help improve health,” said Bernatavitz. Aetna’s PHR is powered by the ActiveHealth patented CareEngine system. In addition to providing a centralized record of member health history, current treatments and personal health data, Aetna’s PHR continuously scans the individual’s health data and claims information – such as physician office, lab, diagnostic treatment and prescriptions – then compares it against highly respected sources of medical literature. When appropriate, it will alert the individual and, in some cases, his or her doctors about possible urgent situations and opportunities to improve care. Members can further personalize the PHR with family health history, immunization records, allergies and emergency contacts. Innovations help drive growth in Aetna plans This year Aetna became the largest consumer-driven health plan in the Federal Employees Health Benefits Program with 26,000 members in its two Aetna HealthFund® plans – the Aetna HealthFund Consumer Driven Health Plan (Health Reimbursement Arrangement or HRA plan) and the Aetna HealthFund High Deductible Health Plan (Health Savings Account or HSA plan). Aetna introduced its HRA to federal enrollees in 2004 and the HSA in 2005. Both plans give federal members access to Aetna’s PPO networks and are currently available to enrollees in 37 states plus the District of Columbia. In 2008, these plans will be expanded to include Vermont. Aetna is the fastest growing health plan in percentage growth across all federal plans for the past four years. In addition, in 2007 Aetna began offering its standalone dental PPO plan nationwide through the Federal Employee Dental and Vision Insurance Program. “We’ve seen tremendous interest from federal enrollees in our plan designs, benefits and the availability of important information to help make informed health care decisions,” said Bernatavitz. “The PHR is another example of how Aetna is offering federal workers more value for their health care dollar.” For more information on Aetna plans, visit www.aetnafeds.com. Aetna is one of the nation’s leading diversified health care benefits companies, serving approximately 34.9 million people with information and resources to help them make better informed decisions about their health care. Aetna offers a broad range of traditional and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life, long-term care and disability plans, and medical management capabilities. Our customers include employer groups, individuals, college students, part-time and hourly workers, health plans and government-sponsored plans. www.aetna.com ]]> tag:health.sourceofnews.net,2007://2.19020 2007-09-14T10:11:35Z 2007-09-15T10:12:42Z

King Faisal Specialist Hospital and Rese...

King Faisal Specialist Hospital and Research Centre to double screening capacity, expand screening program from one to four disorders PerkinElmer, Inc. (NYSE: PKI), a global technology leader in Health Sciences and Photonics, today announced a multi-year agreement with the King Faisal Specialist Hospital and Research Centre in Riyadh, Saudi Arabia, to support its expanded newborn screening program. Under the terms of the agreement, PerkinElmer will provide instrumentation, reagents, software and screening expertise that will help the King Faisal Hospital double its screening capacity by the end of 2008. The contract, to be executed through PerkinElmer’s regional distributor, HVD Vertriebs Gmbh, will also expand the hospital’s program from screening for one disorder to a total of four disorders. “We are pleased to partner with King Faisal Specialist Hospital and Research Centre to aid in the expansion of its newborn screening program,” said Robert F. Friel, President and Chief Operating Officer, PerkinElmer, Inc. “PerkinElmer is committed to supporting early detection programs worldwide with leading neonatal screening technology designed to identify infants at risk for devastating metabolic disorders, enabling early intervention and treatment to save lives and improve quality of life.” Approximately 800,000 babies are born each year in Saudi Arabia, which has a population of about 27.6 million. The King Faisal Hospital is Saudi Arabia’s leading provider of neonatal screening for genetic disorders, which allows for the early identification and treatment of otherwise debilitating or life threatening conditions and has become one of the most widely accepted procedures in preventative pediatrics. Through this expanded initiative with PerkinElmer, the King Faisal Hospital hopes to double its screening rate to 200,000 newborns by the end of 2008, and to 400,000 newborns by the end of 2009. As part of this agreement, the King Faisal Hospital will use Specimen Gate®, PerkinElmer’s screening laboratory information management system (LIMS). This software will allow the hospital to implement a comprehensive solution that will electronically track laboratory workflow from sample receipt and preparation, through the analytical steps, to quality control review, reporting and follow-up. PerkinElmer currently provides the King Faisal Hospital with reagents for screening congenital hypothyroidism (CH), which if left untreated can lead to severe mental retardation. Under the expanded program, which will begin in late 2007, three additional tests will be sourced from PerkinElmer including: congenital adrenal hyperplasia (CAH), a hormonal disorder affecting the adrenal glands; Galactosemia, which if left untreated, can cause poor development or death; and biotinidase deficiency (BIOT), which can lead to seizures, developmental delay, eczema and hearing loss. Factors Affecting Future Performance This press release contains “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to estimates and projections of future earnings per share, cash flow and revenue growth and other financial results, developments relating to our customers and end-markets, and plans concerning business development opportunities. Words such as “believes,” “intends,” “anticipates,” “plans,” “expects,” “projects,” “forecasts,” “will” and similar expressions, and references to guidance, are intended to identify forward-looking statements. Such statements are based on management’s current assumptions and expectations and no assurances can be given that our assumptions or expectations will prove to be correct. A number of important risk factors could cause actual results to differ materially from the results described, implied or projected in any forward-looking statements. These factors include, without limitation: (1) our failure to introduce new products in a timely manner; (2) our ability to execute acquisitions and license technologies, or to successfully integrate acquired businesses and licensed technologies into our existing business or to make them profitable; (3) our failure to protect adequately our intellectual property; (4) the loss of any of our licenses or licensed rights; (5) our ability to compete effectively; (6) fluctuation in our quarterly operating results and our ability to adjust our operations to address unexpected changes; (7) our ability to produce an adequate quantity of products to meet our customers’ demands; (8) our failure to maintain compliance with applicable government regulations; (9) regulatory changes; (10) economic, political and other risks associated with foreign operations; (11) our ability to retain key personnel; (12) restrictions in our credit agreement; (13) our ability to realize the full value of our intangible assets; and (14) other factors which we describe under the caption “Risk Factors” in our most recent annual report on Form 10-K and in our most recent quarterly report on Form 10-Q and in our other filings with the Securities and Exchange Commission. We disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this press release. PerkinElmer, Inc. is a global technology leader driving growth and innovation in Health Sciences and Photonics markets to improve the quality of life. The Company reported revenues of $1.55 billion in 2006, has 8,500 employees serving customers in more than 125 countries, and is a component of the S&P 500 Index. Additional information is available through www.perkinelmer.com or 1-877-PKI-NYSE. ]]> tag:health.sourceofnews.net,2007://2.19019 2007-09-14T10:10:15Z 2007-09-15T10:11:30Z

Pfizer Inc invites investors and the gen...

www.pfizer.com and click on the “the 37th Annual Bank of America Investment Conference” link. Information on accessing and pre-registering for the webcast will be available at www.pfizer.com beginning today. Visitors will be able to view and listen to an archived copy of the webcast at www.pfizer.com. ]]> tag:health.sourceofnews.net,2007://2.19018 2007-09-14T10:09:03Z 2007-09-15T10:10:11Z

Alnylam Pharmaceuticals, Inc. (Nasdaq: A...

www.alnylam.com. A replay of the presentation will be available on the Alnylam website within 48 hours after the event and will be archived for 14 days. About Alnylam Alnylam is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi. The company is applying its therapeutic expertise in RNAi to address significant medical needs, many of which cannot effectively be addressed with small molecules or antibodies, the current major classes of drugs. Alnylam is leading the translation of RNAi as a new class of innovative medicines with peer-reviewed research efforts published in the world’s top scientific journals including Nature, Nature Medicine, and Cell. The company is leveraging these capabilities to build a broad pipeline of RNAi therapeutics; its most advanced program is in Phase II human clinical trials for the treatment of respiratory syncytial virus (RSV) infection. In addition, the company is developing RNAi therapeutics for the treatment of influenza, hypercholesterolemia, and liver cancers, amongst other diseases. The company’s leadership position in fundamental patents, technology, and know-how relating to RNAi has enabled it to form major alliances with leading companies including Merck, Medtronic, Novartis, Biogen Idec, and Roche. The company, founded in 2002, maintains global headquarters in Cambridge, Massachusetts. For more information, visit www.alnylam.com.]]> tag:health.sourceofnews.net,2007://2.19017 2007-09-14T10:07:23Z 2007-09-15T10:08:58Z

Conceptus, Inc. (NASDAQ:CPTS) announces ...

www.conceptus.com and clicking on the link to Live Webcasts. An archived replay will be available for a period of 30 days. About the Essure® Procedure The Essure procedure, approved by the FDA in 2002, is a sterilization procedure that replaces tubal ligation for women. A soft micro-insert is placed into the Fallopian tubes through the cervix using a hysteroscope. Once in place, the device is designed to elicit tissue growth in and around the micro-insert to form an occlusion or blockage in the Fallopian tubes, over three months. An Essure procedure does not require cutting into the body and can be performed in the doctor’s office, a less costly procedure setting, with just a local anesthetic. A woman is able to leave the office about 45 minutes after the procedure is completed. The Essure confirmation test is performed three months after the procedure to confirm that the micro-inserts are in the correct location, the tubes are blocked and that the woman can discontinue temporary birth control. The Essure procedure is 99.80% effective (based on four years of clinical study follow-up data). The probability of pregnancy in 1000 women at 4 years is only 2.0 as compared to 11.8 for surgical tubal ligation procedures studied in CREST. About Conceptus Conceptus, Inc. manufactures and markets the Essure Permanent Birth Control system, an innovative medical device and procedure designed to provide a non-incisional alternative to tubal ligation, which is currently the leading form of birth control worldwide. The availability of the Essure procedure in the U.S. is expected to open up a market currently occupied by incisional tubal ligation and vasectomy, which combined account for more than 1 million procedures annually. Additional information about the Essure procedure is available at www.essure.com or by calling the Essure Information Center at 1-877-ESSURE1. Additional information about Conceptus is available at www.conceptus.com or by calling 1-877-ESSURE2. ]]> tag:health.sourceofnews.net,2007://2.19016 2007-09-14T10:05:09Z 2007-09-15T10:06:53Z

Valeant Pharmaceuticals International (N...

About Valeant: Valeant Pharmaceuticals International (NYSE:VRX) is a global specialty pharmaceutical company that develops, manufactures and markets products primarily in the areas of neurology, infectious disease and dermatology. More information about Valeant can be found at www.valeant.com. Bedoyecta is a trademark of Valeant Pharmaceuticals International or its related companies. For information on Bedoyecta visit www.BedoyectaUS.com or www.BedoyectaMX.com. ]]>